PeptideMD Review

Our assessment

PeptideMD prints the one, two and three month rate for compounded semaglutide and tirzepatide in the same block, so the discount for a longer commitment is a number you can see rather than something you have to ask about. The figure covers the consult, the medication and cold-chain shipping, with no separate membership. The gaps are the usual ones at this tier: no pharmacy named, no clinician named, no state list.

The pricing page is the whole offer

Everything commercial sits on one page. Both GLP-1 plans, all three plan lengths for each, the peptide protocols alongside them, and a statement of what each figure covers. You never have to find a second page, which is no small thing in a category where the qualifier usually lives one click away from the number.

The structure is easy to read too. The one-month rate is the standing rate. The two-month and three-month rates are lower per month and labeled as what they are. You can see the trade between commitment and price without doing arithmetic.

What the figure covers, and what it doesn't

The site says the plan price includes the initial telehealth consult, the compounded medication for the selected term, 503A pharmacy fulfillment, cold-chain shipping and asynchronous provider messaging. It also says there are no hidden fees and that you can cancel at any time. The medication is inside that charge, so nothing sits on top of it.

The stack plans are a different matter. Those bundle a GLP-1 with two or three other compounds under a single figure, and a blend price isn't the price of any one molecule inside it. Don't read a stack figure as what semaglutide or tirzepatide costs here.

The tirzepatide premium is unusually wide

The gap between the two molecules is larger than usual, and it holds at every plan length. If you assume the dual-agonist costs a little more, it costs a great deal more. The three-month tirzepatide rate still sits above the one-month semaglutide rate.

So don't read the entry figure as the price of GLP-1 treatment here. Which molecule a provider recommends will move your bill more than which plan length you pick.

Sourcing is where it thins out

The pharmacy is described as a 503A licensed facility using FDA-registered active ingredients, which is a category rather than a name. No individual prescribing clinician or medical director is named. No list of states served appears anywhere.

The site does say plainly that its compounded products are not FDA-approved and that the FDA does not review them for safety, effectiveness or quality. That is the sentence a seller has the most commercial reason to bury, and this one prints it.